Table 1.
Examples of food protein-derived bioactive peptides and their mechanisms of action. ABCB-1: ATP-binding cassette subfamily B member 1; ACE: angiotensin I-converting enzyme; Ang II: angiotensin II; AT1R: angiotensin II type-1 receptor; CDH-1: cadherin 1; eNOS: endothelial nitric oxide synthase; CCK1: cholecystokinin-1; COX: cyclooxygenase; IRF-8: interferon regulatory factor 8; PGI2–IP.: prostacyclin receptor; ICAM-1: intercellular adhesion molecule-1; SOD: superoxide dismutase; SHR: spontaneously hypertensive rat.
| Peptide | Source | Animal | Activity | Reference | 
|---|---|---|---|---|
| Peptides with antihypertensive effects: RRWQWR, IJWKL and RPYL | Milk, Derived from lactoferrin | SHRs | Reduces Ang II-induced vasoconstriction in isolated rabbit carotid arterial segments. | [11] | 
| IRW | Derived from egg ovotransferrin | SHRs | Dose-dependently attenuates BP by ~10 mmHg and ~40 mmHg in the low- and high-dose groups, respectively, compared with the results obtained with untreated SHRs. Increases the expression of ACE-2, ATP-binding cassette subfamily B member 1, interferon-regulatory factor and cadherin 1 while significantly decreasing the expression of ICAM-1 and VCAM-1 in mesenteric arteries. | [12,13] | 
| EWH (egg white protein hydrolysate) | Egg white protein | SHRs | Improves vascular relaxation and modifies aortic Ang II receptor expression. | [14] | 
| YRGGLEPINF ESIINF | Egg white protein | SHRs | Its vascular-relaxing mechanism is independent of ACE inhibition. | [15] | 
| TRB (Thermolysin- digested rice bran) LRA, YY | Thermolysin-digested rice bran | SHRs | The long-term administration of TRB (50 mg kg−1 d−1) lowers systolic blood pressure compared with that of the control group. TRB reduces ACE activity in the lung in a dose-dependent manner but does not affect ACE activities in the aorta, kidney, and heart tissues. LRA (0.25 mg kg − 1) and YY (0.5 mg kg − 1) lowers blood pressure 4 h after oral administration. | [16] | 
| IQP, VEP | Spirulina platensis hydrolysates | SHRs | Inhibits ACE, Ang II and AT1R. Upregulates ACE2, Ang (1–7), Mas and AT2. | [17] | 
| Salmon gelatine hydrolysate | Salmon | SHRs | ACE and DPP-IV inhibitory activities in vitro. | [18] | 
| SLR, YY, ER, and FR | Papain-digested bovine serum albumin | SHRs | ACE inhibitory activity in vitro and in vivo. | [19] | 
| Hydrolysate fraction | Palm kernel | SHRs | Antihypertensive effects. | [20] | 
| Milk peptides | Milk protein hydrolysate | SHRs | Attenuate the development of hypertension: systolic blood pressure is increased 33 ± 3 mmHg in the control group compared to 18 ± 5 mmHg in the treated group. Improve aorta and mesenteric acetylcholine relaxation. Increase eNOS expression in the aorta. Decrease left ventricular hypertrophy and interstitial fibrosis. | [21] | 
| RVPSL | Egg | SHRs | Dose-dependently decreases systolic blood pressure starting one week after the administration of a maximum dose of 50 mg/kg. Increases the mRNA expression of renin, ACE, and AT1 receptor in the kidney. Decreases the serum Ang II, renin, and aldosterone levels. | [22] | 
| Rapakinin (RIY) | Rapeseed | SHRs | Induces dilatation of mesenteric artery mediated mainly by the PGI2–IP receptor and then CCK–CCK1 receptor-dependent vasorelaxation. | [23] | 
| Other effects VPP | Milk, casein-derived | CSJEL/61 Mice | Attenuates high-fat diet-induced adipose tissue inflammation. | [24] | 
| Hemp seed Protein hydrolysate | Hemp seed | SHRs | Decreases SOD and catalase expression and the total peroxides levels. | [25] | 
| Milk peptides | Fermented milk with Lactococcus lactis NRRL B-50571 | SHRs | Enhance nitric oxide production and antioxidant activity. | [26] | 
| Lunasin | Soy | Apolipoprotein E–deficient (ApoE-/-) mice | Decreases plaque formation in an experimental ApoE2/2 atherosclerotic model. | [27] |